Showing 1 - 20 results of 262,902 for search '(( 10 mg decrease ) OR ( 10 ((greater decrease) OR (((_ decrease) OR (a decrease)))) ))*', query time: 1.47s Refine Results
  1. 1
  2. 2
  3. 3

    Normalized synergy increased with greater recurrence and decreased with greater feedback. by Samantha P. Sherrill (11114128)

    Published 2021
    “…The background heatmap, wherein brighter colors reflect larger normalized synergy values, replots the central tendency of the values shown in <a href="http://www.ploscompbiol.org/article/info:doi/10.1371/journal.pcbi.1009196#pcbi.1009196.g003" target="_blank">Fig 3</a>. …”
  4. 4
  5. 5
  6. 6

    Long-term treatment with rapamycin results in decrease in progenitor cells. by Zhenya Lu (780517)

    Published 2015
    “…Quantitative calculation of DCX-positive cells per field in different groups. Rats treated with 1.0 and 3.0 mg/kg rapamycin demonstrated decrease in DCX-positive cells. …”
  7. 7
  8. 8
  9. 9
  10. 10

    Long-term treatment with rapamycin results in decrease in cellular immune factors. by Zhenya Lu (780517)

    Published 2015
    “…No obvious change was noted among different groups in Il-1β both in brain and blood (A,B). IL-2 was decreased with 1.0 and 3.0 mg/kg rapamycin treatment both in brain and blood (C, D). …”
  11. 11
  12. 12
  13. 13
  14. 14

    Decreased ShcA expression promotes EMT in NMuMG and HaCaT cells. by Baby Periyanayaki Muthusamy (838234)

    Published 2015
    “…<p>(A) ShcA levels, assessed by immunoblotting, in NMuMG and HaCaT cells transfected with ShcA or control siRNA. siShc-a and siShc-b are ShcA siRNAs used in NMuMG cells, and siShc-c and siShc-d are used in HaCaT cells. …”
  15. 15
  16. 16
  17. 17
  18. 18
  19. 19

    Weighted odds ratios reflecting the impact of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints. by Aeron M. Small (9617751)

    Published 2020
    “…<p>Odds ratio and 95% confidence interval is displayed for the effect of a genetically determined 10 mg/dL decrease in LDL-C on safety and efficacy endpoints for White individuals, Black individuals, Hispanic individuals, and inverse variance weighted meta-analysis of White, Black, and Hispanic populations (IVWMA). …”
  20. 20